Societal impact based on global goals should take priority over industrial profit. They seek mandatory civil society involvement and guarantees for affordable medical products. This would secure more funding and institutional influence for health-focused non-profit organizations.
Pharmaceutical companies and industrial firms could face reduced profit margins from pricing rules.